News

UNC Researchers Find Racial Disparities in Treatment for Heart Attack Patients

UNC Researchers Find Racial Disparities in Treatment for Heart Attack Patients

Sameer Arora, MD, a UNC School of Medicine cardiology fellow, led a study reviewing hospitalizations for a certain type of heart attack that occurred over a 15-year period and found consistent differences in the treatment of black and white patients.

UNC Researchers Find Racial Disparities in Treatment for Heart Attack Patients - Read More…

UNC School of Medicine Study Shows Surprise Low-level Ozone Impact on Asthma Patients

UNC School of Medicine Study Shows Surprise Low-level Ozone Impact on Asthma Patients

Michelle Hernandez, MD, associate medical director of the N.C. Children’s Allergy & Asthma Center, led a study that followed 23 asthma patients in North Carolina to show that even with optimized treatment for persistent asthma, patients experienced respiratory and systemic effects from exposure to low levels of ozone.

UNC School of Medicine Study Shows Surprise Low-level Ozone Impact on Asthma Patients - Read More…

UNC Researchers Awarded Emerging Challenges Grants

UNC Researchers Awarded Emerging Challenges Grants

UNC School of Medicine, UNC Medical Center, and NC TraCS Institute awarded $50,000 to two teams of researchers led by Jill Bates, PharmD, Alison Stuebe, MD, and Ana Whitney, MS, to study pharmacogenomics and social determinants of maternal health.

UNC Researchers Awarded Emerging Challenges Grants - Read More…

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity

UNC School of Medicine researchers led by Jenny Ting, PhD, and colleagues, publish a new approach to weight loss and diabetes prevention.

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity - Read More…

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA

UNC School of Medicine researchers led by Mauro Calabrese, PhD, have developed a way to categorize mysterious RNA molecules by their likely function, a big first step toward quickening the discovery of their roles in human health and diseases, such as cancers.

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA - Read More…

Findings could improve treatment for challenging acute leukemia in children

Findings could improve treatment for challenging acute leukemia in children

There is no consensus on the best way to treat mixed phenotype acute leukemia, a rare blood cancer with survival rates of between 47 and 75 percent for children. Researchers from St. Jude Children’s Research Hospital and the University of North Carolina Lineberger Comprehensive Cancer Center, led by Thomas Alexander, MD, MPH, have made important discoveries about the genetics of this disease that could lead to better treatments.

Findings could improve treatment for challenging acute leukemia in children - Read More…

UNC School of Medicine Hosts Annual White Coat Ceremony

UNC School of Medicine Hosts Annual White Coat Ceremony

The UNC School of Medicine’s Class of 2022 received their white coats at the annual event.

UNC School of Medicine Hosts Annual White Coat Ceremony - Read More…

Johnson Honored with Battle Distinguished Cancer Research Award

Johnson Honored with Battle Distinguished Cancer Research Award

Gary Johnson, PhD, the Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, and co-director of UNC Lineberger’s Molecular Therapeutics Program was awarded the 2017-2018 Hyman L. Battle Distinguished Cancer Research Award.

Johnson Honored with Battle Distinguished Cancer Research Award - Read More…

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer

UNC Lineberger’s Angela B. Smith, MD, MS, an associate professor in the UNC School of Medicine Department of Urology and director of urologic oncology, and her collaborators were awarded a contract from the Patient-Centered Outcomes Research Institute to compare bladder removal with medical therapy in bladder cancer patients.

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer - Read More…

For her father, Morgan runs to support cancer research

For her father, Morgan runs to support cancer research

Katie Morgan, PharmD, a clinical pharmacist working with neuro-oncology and genitourinary-oncology patients at the N.C. Cancer Hospital, found her calling during her father's four-year battle with glioblastoma. To honor him and others fighting brain cancer, Morgan is running in the Head for the Cure 5K, which will be held Sept. 8 in Chapel Hill to raise money for brain cancer research.

For her father, Morgan runs to support cancer research - Read More…

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging

As part of the phase 1 clinical trial for patients with Hunter syndrome, Joseph Muenzer, MD, PhD, performed the UNC Clinical Translational and Research Center's first-ever in vivo genome editing therapy, achieving a milestone in his own career.

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging - Read More…

Investigational Treatment for Postpartum Depression Consistently Reduced Symptoms Across Three Trials, Supporting Submission for FDA Approval

Investigational Treatment for Postpartum Depression Consistently Reduced Symptoms Across Three Trials, Supporting Submission for FDA Approval

The findings of the integrated analysis from one phase 2 and two phase 3 pivotal trials were published today in The Lancet. Lead author Samantha Meltzer-Brody, MD, MPH, of the UNC School of Medicine said the promising results mark a major step forward in women’s health care.

Investigational Treatment for Postpartum Depression Consistently Reduced Symptoms Across Three Trials, Supporting Submission for FDA Approval - Read More…

Davis returns to UNC as Chair of Pediatrics

Davis returns to UNC as Chair of Pediatrics

Stephanie Duggins Davis, MD, began her new role as Chair of the Department of Pediatrics and Physician in Chief at NC Children’s Hospital in late July. It’s a return home for the North Carolina native who previously spent 12 years as a member of the pediatrics faculty.

Davis returns to UNC as Chair of Pediatrics - Read More…

Researchers lay the foundation for personalized immune treatments for leukemia

Researchers lay the foundation for personalized immune treatments for leukemia

In the journal Blood Advances, UNC Lineberger’s Ben Vincent, MD, Paul Armistead, MD, PhD, and their collaborators reported early findings from a new study that could aid in the development of immune-based treatments tailored to individual leukemia patients undergoing stem cell transplantation.

Researchers lay the foundation for personalized immune treatments for leukemia - Read More…

 Stem cells show promise as drug delivery tool for childhood brain cancer

Stem cells show promise as drug delivery tool for childhood brain cancer

UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators including Scott Elton, MD, showed they could shrink tumors in laboratory models of medulloblastoma and extend life. Results of this PLOS ONE study provide a necessary step toward developing clinical trials for children.

Stem cells show promise as drug delivery tool for childhood brain cancer - Read More…

Researchers reveal how gene variant is linked to chronic pain after traumatic injury

Researchers reveal how gene variant is linked to chronic pain after traumatic injury

The study, led by Sarah Linnstaedt, PhD, in the Department of Anesthesiology, shows that the reason the variant affects chronic pain outcomes is because it alters the ability of the gene FKBP5 to be regulated by a microRNA.

Researchers reveal how gene variant is linked to chronic pain after traumatic injury - Read More…

Blue Cross NC, UNC Health Alliance agreement lowers Triangle ACA rates by more than 21 percent

Blue Cross NC, UNC Health Alliance agreement lowers Triangle ACA rates by more than 21 percent

Plans will cost $140 less per month on average before subsidies. New agreement means $200 million reduction in healthcare costs for 2019 in Triangle. Statewide, Blue Cross NC is lowering ACA rates by an average of 4.1 percent.

Blue Cross NC, UNC Health Alliance agreement lowers Triangle ACA rates by more than 21 percent - Read More…

Share This: